chunk.id	cdr3.alpha	v.alpha	j.alpha	cdr3.beta	v.beta	d.beta	j.beta	species	mhc.a	mhc.b	mhc.class	antigen.epitope	antigen.gene	antigen.species	reference.id	method.identification	method.frequency	method.singlecell	method.sequencing	method.verification	meta.study.id	meta.cell.subset	meta.subset.frequency	meta.subject.cohort	meta.subject.id	meta.replica.id	meta.clone.id	meta.epitope.id	meta.tissue	meta.donor.MHC	meta.donor.MHC.method	meta.structure.id
1	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	99.722%		amplicon-seq			CD8+			21M	2017		NW8	PBMC			
2	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.126%		amplicon-seq			CD8+			21M	2017		NW8	PBMC			
3				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	83.446%		amplicon-seq			CD8+			21M	2017		NW8	PBMC			
4				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	12.714%		amplicon-seq			CD8+			21M	2017		NW8	PBMC			
5				CASIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.094%		amplicon-seq			CD8+			21M	2017		NW8	PBMC			
6				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.915%		amplicon-seq			CD8+			21M	2017		NW8	PBMC			
7				CASSIFGELFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.259%		amplicon-seq			CD8+			21M	2017		NW8	PBMC			
8				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	42.620%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
9				CASSYYSGGTETQYF	TRBV3-1	TRBD2	TRBJ2-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	27.520%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
10				CASSPTDSPYGQFF	TRBV5-1		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	20.850%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
11				CASSIVRGANTGELFF	TRBV19	TRBD1	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.003%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
12				CASSLAGPGGEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.138%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
13				CASSFGGSTEAFF	TRBV12-4	TRBD2	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.348%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
14				CASTRQGAEAQHF	TRBV12-3	TRBD1	TRBJ1-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.327%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
15				CASSMVAGGYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.267%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
16				CASSWGYEQYF	TRBV12-4		TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.188%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
17				CASSRTSGPYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.145%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
18				CASSRTGSTEAFF	TRBV18	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.143%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
19				CASSITSGPYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.131%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
20				CSARDPQEGTYGYTF	TRBV20-1	TRBD2	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.115%		amplicon-seq			CD8+			21C	2017		NW8	PBMC			
21	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	49.14%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
22	CAVRRTGGSYIPTF	TRAV21	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	26.31%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
23	CAGQLGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	13.14%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
24	CAGLGNFGNEKLTF	TRAV25	TRAJ48					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	9.47%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
25	CAVFDNYGQNFVF	TRAV8-1	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.30%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
26	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.18%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
27	CAVYNTDKLIF	TRAV21	TRAJ34					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.15%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
28	CAAHRDDKIIF	TRAV12-2	TRAJ30					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.13%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
29				CATRGQGGHTEAFF	TRBV27	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	86.66%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
30				CASSIFGEQYF	TRBV19		TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	6.36%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
31				CSVGPGRPGYTF	TRBV29-1	TRBD2,TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.41%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
32				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.52%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
33				CSARPGRVNEKLFF	TRBV20-1	TRBD1	TRBJ1-4	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.32%		amplicon-seq			CD8+			64M	2005		NW8	PBMC			
34	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	51.28%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
35	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	34.05%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
36	CAASPINDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	7.87%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
37	CAFMIAYSGAGSYQLTF	TRAV38-1	TRAJ28					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.62%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
38	CVVSLTGFQKLVF	TRAV8-2	TRAJ8					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.41%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
39	CAVFDNYGQNFVF	TRAV8-1	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.42%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
40				CASSIFGEQYF	TRBV19		TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	23.65%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
41				CATRGQGGHTEAFF	TRBV27	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	21.15%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
42				CASGPTAGGTDTQYF	TRBV12-5	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	15.65%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
43				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	10.89%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
44				CSVAPGQGKNHSNQPQHF	TRBV29-1	TRBD1	TRBJ1-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	10.70%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
45				CASSVVRGVYEQYF	TRBV19	TRBD2,TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	9.19%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
46				CASSSGRSNQPQHF	TRBV12-4		TRBJ1-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	6.44%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
47				CASSIVQGPYNEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.02%		amplicon-seq			CD8+			64M	2007		NW8	PBMC			
48	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	56.015%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
49	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	31.255%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
50	CAGQLGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	6.424%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
51	CAFMIAYSGAGSYQLTF	TRAV38-1	TRAJ28					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.314%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
52	CAEIANYGGSQGNLIF	TRAV13-2	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.759%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
53	CVVSLTGFQKLVF	TRAV8-2	TRAJ8					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.526%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
54	CALGRSSNTGKLIF	TRAV19	TRAJ37					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.247%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
55	CAVFDNYGQNFVF	TRAV8-1	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.179%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
56	CAAAGEGGKLIF	TRAV13-1	TRAJ23					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.161%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
57				CASSVVRGVYEQYF	TRBV19	TRBD2,TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	42.197%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
58				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	19.013%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
59				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	18.308%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
60				CATRGQGGHTEAFF	TRBV27	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	8.753%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
61				CASSIFGEQYF	TRBV19		TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.936%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
62				CASSIVQGPYNEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.036%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
63				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.782%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
64				CASGPTAGGTDTQYF	TRBV12-5	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.155%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
65				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.450%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
66				CASRLGGGNTEAFF	TRBV27	TRBD2,TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.352%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
67				CASSIVAGALNEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.274%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
68				CASSPRAGATDTQYF	TRBV7-2	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.176%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
69				CASSIFGEAFF	TRBV19		TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.117%		amplicon-seq			CD8+			64M	2008		NW8	PBMC			
70	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	53.93%		amplicon-seq			CD8+			64M	2010		NW8	PBMC			
71	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	29.81%		amplicon-seq			CD8+			64M	2010		NW8	PBMC			
72	CAASPINDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	8.07%		amplicon-seq			CD8+			64M	2010		NW8	PBMC			
73	CAFMIAYSGAGSYQLTF	TRAV38-1	TRAJ28					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	5.75%		amplicon-seq			CD8+			64M	2010		NW8	PBMC			
74	CVVSLTGFQKLVF	TRAV8-2	TRAJ8					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.75%		amplicon-seq			CD8+			64M	2010		NW8	PBMC			
75	CAVFDNYGQNFVF	TRAV8-1	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.45%		amplicon-seq			CD8+			64M	2010		NW8	PBMC			
76				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	94.01%		amplicon-seq			CD8+			64M	2010		NW8	PBMC			
77				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.14%		amplicon-seq			CD8+			64M	2010		NW8	PBMC			
78				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.46%		amplicon-seq			CD8+			64M	2010		NW8	PBMC			
79	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	54.889%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
80	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	34.954%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
81	CLVGEPNTNAGKSTF	TRAV4	TRAJ27					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.587%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
82	CAGQLGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.584%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
83	CAAPGGTSYGKLTF	TRAV13-1	TRAJ52					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.561%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
84	CAESPFFSGGYNKLIF	TRAV5	TRAJ4					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.096%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
85	CAAQGESGGSYIPTF	TRAV21	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.929%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
86	CGTDITTDKLIF	TRAV30	TRAJ34					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.857%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
87	CAGQPGTYKYIF	TRAV35	TRAJ40					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.762%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
88	CAVFDNYGQNFVF	TRAV8-1	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.724%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
89	CAFMIAYSGAGSYQLTF	TRAV38-1	TRAJ28					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.534%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
90				CASSVVRGVYEQYF	TRBV19	TRBD2,TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	46.76%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
91				CATRGQGGHTEAFF	TRBV27	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	13.18%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
92				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	10.97%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
93				CASSIVQGPYNEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	10.52%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
94				CASHQTGTGSNQPQHF	TRBV19	TRBD1	TRBJ1-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	5.83%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
95				CASSIFGEQYF	TRBV19		TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.38%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
96				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.63%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
97				CASSSTGHGTDTQYF	TRBV18	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.35%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
98				CASSLRGGWVRGYTF	TRBV12-4	TRBD2,TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.04%		amplicon-seq			CD8+			64M	2014		NW8	PBMC			
99	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	57.755%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
100	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	33.928%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
101	CAGQLGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	5.346%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
102	CAFMIAYSGAGSYQLTF	TRAV38-1	TRAJ28					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.850%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
103	CAAAGEGGKLIF	TRAV13-1	TRAJ23					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.746%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
104	CAVFDNYGQNFVF	TRAV8-1	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.590%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
105	CAESPFFSGGYNKLIF	TRAV5	TRAJ4					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.440%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
106	CAGPLGGNQFYF	TRAV25	TRAJ49					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.156%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
107	CAVQAGDSWGKLQF	TRAV20	TRAJ24					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.127%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
108				CASSVVRGVYEQYF	TRBV19	TRBD2,TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	67.552%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
109				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	11.257%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
110				CATRGQGGHTEAFF	TRBV27	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	11.043%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
111				CASSIVQGPYNEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.139%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
112				CASSLMGGANQGYTF	TRBV27	TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.215%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
113				CASSIFGEQYF	TRBV19		TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.721%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
114				CASHQTGTGSNQPQHF	TRBV19	TRBD1	TRBJ1-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.374%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
115				CASSLRGGWVRGYTF	TRBV12-4	TRBD2,TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.294%		amplicon-seq			CD8+			64M	2016		NW8	PBMC			
116	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	87.25%		amplicon-seq			CD8+			64C	2005		NW8	PBMC			
117	CATVLWGGFKTIF	TRAV17	TRAJ9					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	12.40%		amplicon-seq			CD8+			64C	2005		NW8	PBMC			
118	CAGLFGNEKLTF	TRAV20	TRAJ48					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.22%		amplicon-seq			CD8+			64C	2005		NW8	PBMC			
119	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.10%		amplicon-seq			CD8+			64C	2005		NW8	PBMC			
120				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	99.89%		amplicon-seq			CD8+			64C	2005		NW8	PBMC			
121	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	56.945%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
122	CATARMDDKIIF	TRAV17	TRAJ30					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	12.823%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
123	CVVSESTGFQKLVF	TRAV8-2	TRAJ8					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	11.328%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
124	CLVGGYNFNKFYF	TRAV4	TRAJ21					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	6.574%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
125	CATVLWGGFKTIF	TRAV17	TRAJ9					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	6.400%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
126	CARKGDKLVF	TRAV25	TRAJ47					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.389%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
127	CAGLEGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.345%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
128	CAVNMLDSGYSTLTF	TRAV12-2	TRAJ11					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.828%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
129	CAGQEGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.668%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
130	CAYLNAGGTSYGKLTF	TRAV38-1	TRAJ52					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.277%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
131	CAGQTGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.207%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
132	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.150%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
133				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	44.931%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
134				CASSYYSGGTETQYF	TRBV3-1	TRBD2	TRBJ2-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	26.754%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
135				CASSPTDSPYGQFF	TRBV5-1		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	21.974%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
136				CASSIVRGANTGELFF	TRBV19	TRBD1	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.379%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
137				CASSLAGPGGEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.852%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
138				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.114%		amplicon-seq			CD8+			64C	2006		NW8	PBMC			
139	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	90.37%		amplicon-seq			CD8+			64C	2010		NW8	PBMC			
140	CATVLWGGFKTIF	TRAV17	TRAJ9					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	9.06%		amplicon-seq			CD8+			64C	2010		NW8	PBMC			
141	CAGLFGNEKLTF	TRAV20	TRAJ48					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.32%		amplicon-seq			CD8+			64C	2010		NW8	PBMC			
142	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.17%		amplicon-seq			CD8+			64C	2010		NW8	PBMC			
143				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	78.09%		amplicon-seq			CD8+			64C	2010		NW8	PBMC			
144				CASSLAGPGGEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	19.27%		amplicon-seq			CD8+			64C	2010		NW8	PBMC			
145				CASSPTDSPYGQFF	TRBV5-1		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.14%		amplicon-seq			CD8+			64C	2010		NW8	PBMC			
146				CASSYYSGGTETQYF	TRBV3-1	TRBD2	TRBJ2-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.70%		amplicon-seq			CD8+			64C	2010		NW8	PBMC			
147				CASSVFGEQYF	TRBV19		TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.29%		amplicon-seq			CD8+			64C	2010		NW8	PBMC			
148	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	68.48%		amplicon-seq			CD8+			64C	2014		NW8	PBMC			
149	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	15.57%		amplicon-seq			CD8+			64C	2014		NW8	PBMC			
150	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	13.83%		amplicon-seq			CD8+			64C	2014		NW8	PBMC			
151	CATVLWGGFKTIF	TRAV17	TRAJ9					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.10%		amplicon-seq			CD8+			64C	2014		NW8	PBMC			
152				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	99.49%		amplicon-seq			CD8+			64C	2014		NW8	PBMC			
153				CASSLAGPGGEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.25%		amplicon-seq			CD8+			64C	2014		NW8	PBMC			
154				CATRGQGGHTEAFF	TRBV27	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.11%		amplicon-seq			CD8+			64C	2014		NW8	PBMC			
155	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	70.20%		amplicon-seq			CD8+			64C	2015		NW8	PBMC			
156	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	18.20%		amplicon-seq			CD8+			64C	2015		NW8	PBMC			
157	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	10.04%		amplicon-seq			CD8+			64C	2015		NW8	PBMC			
158	CATVLWGGFKTIF	TRAV17	TRAJ9					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.54%		amplicon-seq			CD8+			64C	2015		NW8	PBMC			
159				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	99.30%		amplicon-seq			CD8+			64C	2015		NW8	PBMC			
160				CATRGQGGHTEAFF	TRBV27	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.22%		amplicon-seq			CD8+			64C	2015		NW8	PBMC			
161	CALIGITGGGNKLTF	TRAV1-2	TRAJ10					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	89.80%		amplicon-seq			CD8+			35M	2006		NW8	PBMC			
162	CAASLLSNNDMRF	TRAV29DV5	TRAJ43					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	9.71%		amplicon-seq			CD8+			35M	2006		NW8	PBMC			
163	CLVGDITGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.28%		amplicon-seq			CD8+			35M	2006		NW8	PBMC			
164				CASSLGQLEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	99.98%		amplicon-seq			CD8+			35M	2006		NW8	PBMC			
165				CASITDVPMSTDTQYF	TRBV6-1	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.13%		amplicon-seq			CD8+			35M	2006		NW8	PBMC			
166	CALPHASGGSYIPTF	TRAV16	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	87.18%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
167	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.80%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
168	CAENRGKRAGTALIF	TRAV13-2	TRAJ15					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.76%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
169	CATEDTGNQFYF	TRAV17	TRAJ49					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.67%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
170	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.74%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
171	CSVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.68%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
172	CAVQATAGAQKLVF	TRAV20	TRAJ54					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.38%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
173	CAMIAPDSGGGADGLTF	TRAV12-3	TRAJ45					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.26%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
174	CAMSEDNDMRF	TRAV12-3	TRAJ43					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.23%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
175				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	70.67%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
176				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	27.91%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
177				CASSRSGGGGLTGELFF	TRBV27	TRBD2	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.69%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
178				CASIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.61%		amplicon-seq			CD8+			35M	2007		NW8	PBMC			
179	CALPHASGGSYIPTF							HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	81.11%		amplicon-seq			CD8+			35M	2008		NW8	PBMC			
180	CAAKTGGGNKLTF							HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	17.10%		amplicon-seq			CD8+			35M	2008		NW8	PBMC			
181	CAAKTGGGNKLTF							HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.79%		amplicon-seq			CD8+			35M	2008		NW8	PBMC			
182				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	73.39%		amplicon-seq			CD8+			35M	2008		NW8	PBMC			
183				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	16.41%		amplicon-seq			CD8+			35M	2008		NW8	PBMC			
184				CASSSDRSWTDEAFF	TRBV11-2	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	6.55%		amplicon-seq			CD8+			35M	2008		NW8	PBMC			
185				CASSLLGRQADYGYTF	TRBV7-9	TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.28%		amplicon-seq			CD8+			35M	2008		NW8	PBMC			
186				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.89%		amplicon-seq			CD8+			35M	2008		NW8	PBMC			
187	CLVGDITGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	82.33%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
188	CLVGDLTGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	16.75%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
189	CALIGITGGGNKLTF	TRAV1-2	TRAJ10					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.45%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
190	CLVGDVTGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.39%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
191				CASSLGQIEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	82.17%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
192				CASSLGQLEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	7.25%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
193				CASSLGQLEAFF	TRBV5-5		TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	7.03%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
194				CASSSDRSWTDEAFF	TRBV11-2	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.75%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
195				CSVGPGRPGYTF	TRBV29-1	TRBD2,TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.60%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
196				CASSLGQIEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.49%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
197				CASSLGHLEQYF	TRBV5-5		TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.42%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
198				CSARPGRVNEKLFF	TRBV20-1	TRBD1	TRBJ1-4	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.39%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
199				CASSLGQLEAFF	TRBV5-5	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.24%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
200				CASSEGQFMNTEAFF	TRBV9		TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.23%		amplicon-seq			CD8+			35M	2009		NW8	PBMC			
201	CLVGDLTGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	98.95%		amplicon-seq			CD8+			35M	2013		NW8	PBMC			
202	CLVGDITGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.64%		amplicon-seq			CD8+			35M	2013		NW8	PBMC			
203	CALIGITGGGNKLTF	TRAV1-2	TRAJ10					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.14%		amplicon-seq			CD8+			35M	2013		NW8	PBMC			
204	CAARANDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.10%		amplicon-seq			CD8+			35M	2013		NW8	PBMC			
205				CASSLGQLEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	98.21%		amplicon-seq			CD8+			35M	2013		NW8	PBMC			
206				CASSLGQIEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.81%		amplicon-seq			CD8+			35M	2013		NW8	PBMC			
207				CSVGPGRPGYTF	TRBV29-1	TRBD2,TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.40%		amplicon-seq			CD8+			35M	2013		NW8	PBMC			
208				CSARPGRVNEKLFF	TRBV20-1	TRBD1	TRBJ1-4	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.30%		amplicon-seq			CD8+			35M	2013		NW8	PBMC			
209	CATGDPPLQGGSEKLVF	TRAV17	TRAJ57					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	46.72%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
210	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	31.65%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
211	CAASSAAGNKLTF	TRAV36DV7	TRAJ17					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	9.51%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
212	CAASPINDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	5.83%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
213	CAFMIAYSGAGSYQLTF	TRAV38-1	TRAJ28					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.69%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
214	CVVSLTGFQKLVF	TRAV8-2	TRAJ8					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.52%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
215	CAVFDNYGQNFVF	TRAV8-1	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.53%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
216	CDNNNDMRF	TRAV16	TRAJ43					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.26%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
217				CASTERGVLTDTQYF	TRBV12-4	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	93.68%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
218				CASSVQLPLGVPYEQYF	TRBV4-2	TRBD2,TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.81%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
219				CANSRGGSDNEQFF	TRBV6-4	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.49%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
220				CASSVVAGPYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.57%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
221				CASSIVAGSYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.50%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
222				CASSIVSGPYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.36%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
223				CASSIVTGPYNEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.22%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
224				CASSIVAGGDQPQHF	TRBV19	TRBD1	TRBJ1-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.22%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
225				CASSSDRSWTDEAFF	TRBV11-2	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.18%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
226				CASSIVAGSYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.11%		amplicon-seq			CD8+			35C	2006		NW8	PBMC			
227	CAARANDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	78.900%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
228	CAGQGNYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	8.753%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
229	CAGQEGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	5.496%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
230	CLVGGGSQGNLIF	TRAV4	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.098%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
231	CAGQGGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.539%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
232	CAGQLGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.401%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
233	CAGQLGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.221%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
234	CATARGFGNEKLTF	TRAV13-2	TRAJ48					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.485%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
235				CASTERGVLTDTQYF	TRBV12-4	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	72.029%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
236				CASSVQLPLGVPYEQYF	TRBV4-2	TRBD2,TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	6.383%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
237				CANSRGGSDNEQFF	TRBV6-4	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.751%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
238				CASSIVAGSYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.347%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
239				CASSIVTGPYNEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.880%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
240				CASSVVAGPYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.788%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
241				CASSIVAGSYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.201%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
242				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.054%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
243				CASSIVAGAYNEQFF	TRBV19	TRBD1	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.660%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
244				CASSISGLNTDTQYF	TRBV19	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.422%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
245				CASSIVTGAYNEQFF	TRBV19	TRBD1	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.257%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
246				CASTLGPGSYEQYF	TRBV7-9		TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.238%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
247				CASSIVAGGDQPQHF	TRBV19	TRBD1	TRBJ1-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.202%		amplicon-seq			CD8+			35C	2007		NW8	PBMC			
248	CAARANDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	81.10%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
249	CAGQLGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	7.04%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
250	CLVGGGSQGNLIF	TRAV4	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.88%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
251	CAGLEGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.26%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
252	CAEIVNYGGSQGNLIF	TRAV13-2	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.80%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
253	CAGQEGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.83%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
254				CASTERGVLTDTQYF	TRBV12-4	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	73.34%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
255				CASSIVAGSYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	7.50%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
256				CASSIVTGPYNEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	5.39%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
257				CANSRGGSDNEQFF	TRBV6-4	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.56%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
258				CASSVQLPLGVPYEQYF	TRBV4-2	TRBD2,TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.54%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
259				CASSVVAGPYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.73%		amplicon-seq			CD8+			35C	2010		NW8	PBMC			
260	CAGQEGYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	72.48%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
261	CAARANDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	23.54%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
262	CAGQGNYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.38%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
263	CLVGGGSQGNLIF	TRAV4	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.64%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
264	CAGQGNYGGSQGNLIF	TRAV35	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.40%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
265	CAVKKDYTNAGKSTF	TRAV8-1	TRAJ27					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.14%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
266				CASSIVAGSYNEQFF	TRBV19	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	75.59%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
267				CANSRGGSDNEQFF	TRBV6-4	TRBD2	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	17.67%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
268				CASTERGVLTDTQYF	TRBV12-4	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.98%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
269				CASSSDRSWTDEAFF	TRBV11-2	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.63%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
270				CASSIVAGAYNEQFF	TRBV19	TRBD1	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.25%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
271				CASSVFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.22%		amplicon-seq			CD8+			35C	2013		NW8	PBMC			
272	CLVGDLTGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	99.80%		amplicon-seq			CD8+			76C	2006		NW8	PBMC			
273	CAVRNDYKLSF	TRAV1-2	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.11%		amplicon-seq			CD8+			76C	2006		NW8	PBMC			
274				CASSLGQLEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	99.62%		amplicon-seq			CD8+			76C	2006		NW8	PBMC			
275				CASITDVPMSTDTQYF	TRBV6-1	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.26%		amplicon-seq			CD8+			76C	2006		NW8	PBMC			
276	CLVGDITGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	44.82%		amplicon-seq			CD8+			76C	2008		NW8	PBMC			
277	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	36.56%		amplicon-seq			CD8+			76C	2008		NW8	PBMC			
278	CLVGDVTGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	18.06%		amplicon-seq			CD8+			76C	2008		NW8	PBMC			
279	CLVGDLTGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.34%		amplicon-seq			CD8+			76C	2008		NW8	PBMC			
280				CASSLGQLEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	98.70%		amplicon-seq			CD8+			76C	2008		NW8	PBMC			
281				CASITDVPMSTDTQYF	TRBV6-1	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.68%		amplicon-seq			CD8+			76C	2008		NW8	PBMC			
282				CASSLGQLEAFF	TRBV5-5		TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.17%		amplicon-seq			CD8+			76C	2008		NW8	PBMC			
283				CASSLGQIEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.14%		amplicon-seq			CD8+			76C	2008		NW8	PBMC			
284	CLVGDITGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	55.27%		amplicon-seq			CD8+			76C	2010		NW8	PBMC			
285	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	22.28%		amplicon-seq			CD8+			76C	2010		NW8	PBMC			
286	CLVGDVTGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	21.96%		amplicon-seq			CD8+			76C	2010		NW8	PBMC			
287	CLVGDLTGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.36%		amplicon-seq			CD8+			76C	2010		NW8	PBMC			
288				CASSLGQLEAFF	TRBV5-5		TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	67.53%		amplicon-seq			CD8+			76C	2010		NW8	PBMC			
289				CASSLGQIEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	23.81%		amplicon-seq			CD8+			76C	2010		NW8	PBMC			
290				CASSLGQLEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.28%		amplicon-seq			CD8+			76C	2010		NW8	PBMC			
291				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.34%		amplicon-seq			CD8+			76C	2010		NW8	PBMC			
292				CASSLGQIEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.58%		amplicon-seq			CD8+			76C	2010		NW8	PBMC			
293				CASSLGQLEAFF	TRBV5-5	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.58%		amplicon-seq			CD8+			76C	2010		NW8	PBMC			
294	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	99.74%		amplicon-seq			CD8+			76C	2012		NW8	PBMC			
295	CAARANDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.26%		amplicon-seq			CD8+			76C	2012		NW8	PBMC			
296				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	96.70%		amplicon-seq			CD8+			76C	2012		NW8	PBMC			
297	CAGTDGGATNKLIF	TRAV36DV7	TRAJ32					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	62.35%		amplicon-seq			CD8+			76C	2014		NW8	PBMC			
298	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	29.10%		amplicon-seq			CD8+			76C	2014		NW8	PBMC			
299	CAMTLVQEAGANSKLTF	TRAV14DV4	TRAJ56					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.36%		amplicon-seq			CD8+			76C	2014		NW8	PBMC			
300	CAGGGAAGNKLTF	TRAV36DV7	TRAJ17					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.18%		amplicon-seq			CD8+			76C	2014		NW8	PBMC			
301				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	71.40%		amplicon-seq			CD8+			76C	2014		NW8	PBMC			
302				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	15.69%		amplicon-seq			CD8+			76C	2014		NW8	PBMC			
303				CASSFWTGHADTQYF	TRBV7-9	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	5.52%		amplicon-seq			CD8+			76C	2014		NW8	PBMC			
304				CASSISGLNTDTQYF	TRBV19	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.58%		amplicon-seq			CD8+			76C	2014		NW8	PBMC			
305	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	98.39%		amplicon-seq			CD8+			76C	2016		NW8	PBMC			
306	CALPHASGGSYIPTF	TRAV16	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.81%		amplicon-seq			CD8+			76C	2016		NW8	PBMC			
307	CAGTDGGATNKLIF	TRAV21	TRAJ32					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.81%		amplicon-seq			CD8+			76C	2016		NW8	PBMC			
308				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	95.66%		amplicon-seq			CD8+			76C	2016		NW8	PBMC			
309				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.79%		amplicon-seq			CD8+			76C	2016		NW8	PBMC			
310				CAIGGQGSYEQYF	TRBV10-3	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.20%		amplicon-seq			CD8+			76C	2016		NW8	PBMC			
311	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	98.881%		amplicon-seq			CD8+			76C	2017		NW8	PBMC			
312				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	79.496%		amplicon-seq			CD8+			76C	2017		NW8	PBMC			
313				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	17.882%		amplicon-seq			CD8+			76C	2017		NW8	PBMC			
314				CASTLQGGTGELFF	TRBV27	TRBD2,TRBD1	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.722%		amplicon-seq			CD8+			76C	2017		NW8	PBMC			
315				CASSISGLNTDTQYF	TRBV19	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.471%		amplicon-seq			CD8+			76C	2017		NW8	PBMC			
316				CASSIFGELFF	TRBV19		TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.280%		amplicon-seq			CD8+			76C	2017		NW8	PBMC			
317				CASSPTDSPYGQFF	TRBV5-1		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.125%		amplicon-seq			CD8+			76C	2017		NW8	PBMC			
318				CASSYYSGGTETQYF	TRBV3-1	TRBD2	TRBJ2-5	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.110%		amplicon-seq			CD8+			76C	2017		NW8	PBMC			
319				CASSIVQGPLNEQFF	TRBV19	TRBD2,TRBD1	TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.088%		amplicon-seq			CD8+			76C	2017		NW8	PBMC			
320	CAARSNDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	78.89%		amplicon-seq			CD8+			76M	2006		NW8	PBMC			
321	CAFTDGGATNKLIF	TRAV36DV7	TRAJ32					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	18.81%		amplicon-seq			CD8+			76M	2006		NW8	PBMC			
322	CAVRDGENDMRF	TRAV3	TRAJ43					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.26%		amplicon-seq			CD8+			76M	2006		NW8	PBMC			
323				CASSLRGVWTDTQYF	TRBV12-4	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	64.53%		amplicon-seq			CD8+			76M	2006		NW8	PBMC			
324				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	35.22%		amplicon-seq			CD8+			76M	2006		NW8	PBMC			
325	CAVQTDKLIF	TRAV41	TRAJ34					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	43.66%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
326	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	27.10%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
327	CAAPLYSGGGADGLTF	TRAV41	TRAJ45					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	10.32%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
328	CAENAGGTSYGKLTF	TRAV13-2	TRAJ52					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.95%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
329	CAASMGGANNLFF	TRAV13-1	TRAJ36					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.01%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
330	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.58%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
331				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	84.64%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
332				CASSIVGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	8.98%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
333				CASSLLAGAADTQYF	TRBV7-9	TRBD2	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.22%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
334				CASKLMGGANGYTF	TRBV27	TRBD2,TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.96%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
335				CASSDSAGDGGELFF	TRBV6-4	TRBD2	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.85%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
336				CASSISGLNTDTQYF	TRBV19	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.67%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
337				CASSLRAGAADTQYF	TRBV7-9	TRBD2	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.43%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
338				CASSLGASTDTQYF	TRBV12-3		TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.33%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
339				CASSFWTGHADTQYF	TRBV7-9	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.31%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
340				CASTLQGGTGELFF	TRBV27	TRBD2,TRBD1	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.31%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
341				CASSLHPRGGLTPISYEQYF	TRBV7-8	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.13%		amplicon-seq			CD8+			76M	2007		NW8	PBMC			
342	CAARSNDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	90.48%		amplicon-seq			CD8+			76M	2008		NW8	PBMC			
343	CAVRDGENDMRF	TRAV3	TRAJ43					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	9.46%		amplicon-seq			CD8+			76M	2008		NW8	PBMC			
344				CASSLRGVWTDTQYF	TRBV12-4	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	75.18%		amplicon-seq			CD8+			76M	2008		NW8	PBMC			
345				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	7.93%		amplicon-seq			CD8+			76M	2008		NW8	PBMC			
346				CASRLQGGNTEAFF	TRBV27	TRBD2,TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	7.72%		amplicon-seq			CD8+			76M	2008		NW8	PBMC			
347				CASSLAPGPYSGANVLTF	TRBV5-1		TRBJ2-6	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.19%		amplicon-seq			CD8+			76M	2008		NW8	PBMC			
348				CSARGGRDVGELFF	TRBV20-1	TRBD1	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.70%		amplicon-seq			CD8+			76M	2008		NW8	PBMC			
349				CASSLASQGTDTQYF	TRBV11-2		TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.89%		amplicon-seq			CD8+			76M	2008		NW8	PBMC			
350	CAARSNDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	51.39%		amplicon-seq			CD8+			76M	2013		NW8	PBMC			
351	CALSELNSNSGYALNF	TRAV19	TRAJ41					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	22.84%		amplicon-seq			CD8+			76M	2013		NW8	PBMC			
352	CALDPLDSGNTPLVF	TRAV19	TRAJ29					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	21.17%		amplicon-seq			CD8+			76M	2013		NW8	PBMC			
353	CAEFDNYGQNFVF	TRAV8-3	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.20%		amplicon-seq			CD8+			76M	2013		NW8	PBMC			
354				CASSLRGVWTDTQYF	TRBV12-4	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	45.98%		amplicon-seq			CD8+			76M	2013		NW8	PBMC			
355				CASRLQGGNTEAFF	TRBV27	TRBD2,TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	23.08%		amplicon-seq			CD8+			76M	2013		NW8	PBMC			
356				CASSLAPGPYSGANVLTF	TRBV5-1		TRBJ2-6	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	12.46%		amplicon-seq			CD8+			76M	2013		NW8	PBMC			
357				CSARGGRDVGELFF	TRBV20-1	TRBD1	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	11.75%		amplicon-seq			CD8+			76M	2013		NW8	PBMC			
358				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.68%		amplicon-seq			CD8+			76M	2013		NW8	PBMC			
359				CASSLASQGTDTQYF	TRBV11-2		TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.62%		amplicon-seq			CD8+			76M	2013		NW8	PBMC			
360	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	61.61%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
361	CAYVMGNNNDMRF	TRAV13-1	TRAJ43					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	23.16%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
362	CAVSDTGTASKLTF	TRAV8-6	TRAJ44					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	13.69%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
363	CAVIPNYGGSQGNLIF	TRAV8-1	TRAJ42					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.72%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
364	CAVGNNAGNMLTF	TRAV20	TRAJ39					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.29%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
365				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	57.62%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
366				CASSISGLNTDTQYF	TRBV19	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	18.62%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
367				CASSLLAGAADTQYF	TRBV7-9	TRBD2	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	6.59%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
368				CASSFWTGHADTQYF	TRBV7-9	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	6.34%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
369				CASTLQGGTGELFF	TRBV27	TRBD2,TRBD1	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.11%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
370				CASKLMGGANGYTF	TRBV27	TRBD2,TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.71%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
371				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.91%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
372				CASSPGQGTDTQYF	TRBV5-1	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.42%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
373				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.63%		amplicon-seq			CD8+			76M	2014		NW8	PBMC			
374	CAAPLYSGGGADGLTF	TRAV41	TRAJ45					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	68.44%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
375	CAVMADGQNFVF	TRAV21	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	15.75%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
376	CLVGDLTGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.37%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
377	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.34%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
378	CAEGGHSGGYQKVTF	TRAV5	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.53%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
379	CLVGDITGGSYIPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.96%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
380	CLVGDLTGGSYRPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.92%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
381	CAVMADGQKFVF	TRAV21	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.82%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
382	CALSEAISGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.42%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
383	CALSEAVYGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.35%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
384	CAERLAGGTSYGKLTF	TRAV5	TRAJ52					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.35%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
385	CALSEASSGGYQKVTF	TRAV19	TRAJ13					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.33%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
386	CLVGDITGGSYRPTF	TRAV4	TRAJ6					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.17%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
387				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	64.92%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
388				CASSIVGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	8.69%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
389				CASSFWTGHADTQYF	TRBV7-9	TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	5.50%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
390				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	5.30%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
391				CASKLMGGANGYTF	TRBV27	TRBD2,TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.74%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
392				CASSLGQIEQYF	TRBV5-5	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.47%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
393				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.18%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
394				CASSLLAGAADTQYF	TRBV7-9	TRBD2	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.10%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
395				CASSISGLANYEQYF	TRBV19	TRBD2	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.85%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
396				CASSIVGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.84%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
397				CASKLMGGANGDTF	TRBV27	TRBD2,TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.68%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
398				CASTLQGGTGELFF	TRBV27	TRBD2,TRBD1	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.52%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
399				CASSLRAGAADTQYF	TRBV7-9	TRBD2	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.41%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
400				CASSISGLNTDTQYF	TRBV19	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.35%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
401				CASSIVGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.33%		amplicon-seq			CD8+			76M	2015		NW8	PBMC			
402	CAARSNDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	47.57%		amplicon-seq			CD8+			76M	2016		NW8	PBMC			
403	CALSELNSNSGYALNF	TRAV19	TRAJ41					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	23.62%		amplicon-seq			CD8+			76M	2016		NW8	PBMC			
404	CALDPLDSGNTPLVF	TRAV19	TRAJ29					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	22.03%		amplicon-seq			CD8+			76M	2016		NW8	PBMC			
405	CAEFDNYGQNFVF	TRAV8-3	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.07%		amplicon-seq			CD8+			76M	2016		NW8	PBMC			
406				CASSLRGVWTDTQYF	TRBV12-4	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	44.92%		amplicon-seq			CD8+			76M	2016		NW8	PBMC			
407				CASRLQGGNTEAFF	TRBV27	TRBD2,TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	22.00%		amplicon-seq			CD8+			76M	2016		NW8	PBMC			
408				CASSLAPGPYSGANVLTF	TRBV5-1		TRBJ2-6	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	14.52%		amplicon-seq			CD8+			76M	2016		NW8	PBMC			
409				CSARGGRDVGELFF	TRBV20-1	TRBD1	TRBJ2-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	11.87%		amplicon-seq			CD8+			76M	2016		NW8	PBMC			
410				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	4.15%		amplicon-seq			CD8+			76M	2016		NW8	PBMC			
411				CASSLASQGTDTQYF	TRBV11-2		TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.26%		amplicon-seq			CD8+			76M	2016		NW8	PBMC			
412	CAARSNDYKLSF	TRAV13-1	TRAJ20					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	61.80%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
413	CAVRDGENDMRF	TRAV3	TRAJ43					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	13.36%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
414	CAEFDNYGQNFVF	TRAV8-3	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	13.29%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
415	CAVSDAGTASKLTF	TRAV8-6	TRAJ44					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	8.24%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
416	CAASGSGGQNFVF	TRAV13-1	TRAJ26					HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	3.22%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
417				CASSIFGEQFF	TRBV19		TRBJ2-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	62.63%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
418				CASSLRGVWTDTQYF	TRBV12-4	TRBD2,TRBD1	TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	29.84%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
419				CASSRRPGQQNSYEQYF	TRBV12-4	TRBD1	TRBJ2-7	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.48%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
420				CASRATGGETEAFF	TRBV27	TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	2.04%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
421				CASRLQGGNTEAFF	TRBV27	TRBD2,TRBD1	TRBJ1-1	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	1.63%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
422				CASSLQGGAAGGYTF	TRBV27	TRBD2,TRBD1	TRBJ1-2	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.37%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
423				CASSIFGEQYF	TRBV19		TRBJ2-3	HomoSapiens	HLA-B*44:03	B2M	MHCI	NEGVKAAW	IE2	CMV	PMID:33101265	tetramer-sort	0.10%		amplicon-seq			CD8+			76M	2017		NW8	PBMC			
